These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11477561)

  • 41. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DTCs in breast cancer: clinical research and practice.
    Janni W; Rack B; Kasprowicz N; Scholz C; Hepp P
    Recent Results Cancer Res; 2012; 195():173-8. PubMed ID: 22527504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of micrometastatic bone marrow involvement.
    Braun S; Pantel K
    Breast Cancer Res Treat; 1998; 52(1-3):201-16. PubMed ID: 10066083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
    de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
    J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
    Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
    Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
    Diel IJ; Kaufmann M; Goerner R; Costa SD; Kaul S; Bastert G
    J Clin Oncol; 1992 Oct; 10(10):1534-9. PubMed ID: 1403032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer.
    Song IH; Kim YA; Lee H; Park HS; Park IA; Sim CK; Lee MS; Gong G; Lee HJ
    Immunol Res; 2019 Dec; 67(6):469-477. PubMed ID: 31900802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma.
    Leinung S; Würl P; Weiss CL; Röder I; Schönfelder M
    Langenbecks Arch Surg; 2000 Aug; 385(5):337-43. PubMed ID: 11026705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
    Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
    Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
    Concha A; Cabrera T; Ruiz-Cabello F; Garrido F
    Int J Cancer Suppl; 1991; 6():146-54. PubMed ID: 2066180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody.
    Malik P; Baba E; Strominger JL
    Tissue Antigens; 1999 Jun; 53(6):576-9. PubMed ID: 10395109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse.
    Braun S; Schindlbeck C; Hepp F; Janni W; Kentenich C; Riethmüller G; Pantel K
    J Clin Oncol; 2001 Jan; 19(2):368-75. PubMed ID: 11208828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.
    Lin X; Wang X; Capek HL; Simone LC; Tuli A; Morris CR; Reber AJ; Solheim JC
    Cancer Immunol Immunother; 2009 May; 58(5):729-36. PubMed ID: 18828016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
    Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
    Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of MHC-class-I antigens in human carcinomas and sarcomas analyzed by isoelectric focusing.
    Wang P; Vánky F; Li SL; Végh Z; Persson U; Klein E
    Int J Cancer Suppl; 1991; 6():106-16. PubMed ID: 2066176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.